QuidelOrtho
QDEL
$38.26
Share price
-1.16%
Change (1 day)
-58.49%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total debt
Total debt on the balance sheet as of December 2023 : $2.61 B
According to QuidelOrtho's latest financial reports the company's total debt is $2.61 B. A company’s total debt is the sum of all current and non-current debts.
QuidelOrtho - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.61 B | -8.25% |
| 2022-12-31 | $2.84 B | 1945.3% |
| 2021-12-31 | $0.13 B | 28.38% |
| 2020-12-31 | $0.10 B | -3.38% |
| 2019-12-31 | $0.11 B | 4.4% |
| 2018-12-31 | $0.10 B | -72.94% |
| 2017-12-31 | $0.39 B | 175.35% |
| 2016-12-31 | $0.14 B | -2.42% |
| 2015-12-31 | $0.14 B | 3.38% |
| 2014-12-31 | $0.14 B | 2470.22% |
| 2013-12-31 | $5.56 M | -49.15% |
| 2012-12-31 | $10.94 M | -78.01% |
| 2011-12-31 | $49.77 M | -37.82% |
| 2010-12-31 | $80.05 M | 1084.06% |
| 2009-12-31 | $6.76 M | -3.4% |
| 2008-12-31 | $6.99 M | -9.85% |
| 2007-12-31 | $7.76 M | -8% |
| 2006-12-31 | $8.43 M | -42.63% |
| 2005-12-31 | $14.71 M | 52.01% |
| 2004-12-31 | $9.67 M | -5.09% |
| 2003-12-31 | $10.19 M | -4.26% |
| 2002-12-31 | $10.65 M | -22.42% |
| 2001-12-31 | $13.72 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 1,235.72% | 🇺🇸 USA |
 Becton Dickinson BDX | $16.11 B | 516.27% | 🇺🇸 USA |
 Danaher DHR | $19.53 B | 647.33% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 72.52% | 🇺🇸 USA |
 OraSure Technologies OSUR | $13.5 M | -99.48% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $30.95 M | -98.82% | 🇺🇸 USA |